Brought to you by 
Novocure enters $150mm loan financing; pays off existing debt
09 Feb 2018
Executive Summary
Novocure Ltd. (developed the Tumor Treating Fields alternating electrical field technology to treat cancer) entered into a $150mm non-dilutive term loan with BioPharma Credit PLC (managed by Pharmakon Advisors). The company drew down the loan in full immediately, and will use the proceeds to repay obligations under a 2015 $100mm loan agreement with Pharmakon's BioPharma Secured Investments
Deal Industry
- Medical Devices
-
Medical Devices
- Radiofrequency Devices
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Novocure enters $150mm loan financing; pays off existing debt
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice